Odyssey Thera compounding profiling service
Using cutting-edge Protein-fragment Complementation Assay technology from Odyssey Thera, Lonza is able to offer profiling services that can shape and influence critical decisions about drug candidates.
This unique cell-wide analysis platform broadly addresses target classes, signalling pathways and cellular processes. Classify drugs by comparison to an extensive compound database defining MOA and predicting safety threats.
It features: analysis of drug activity for any target class or pathway across cellular systems; high-content/high-throughput data capture and analysis; in-depth data interpretation including comparison to an extensive database of known drugs and toxicants; improved decision making throughout the development process.
Suitable applications include: target validation, HTS, SAR testing, toxicity and drug safety screens and compound selectivity testing.
Phone: 1300 657508
Lonza TheraPEAK AmpliCell Cytokines and TheraPEAK 293-GT Medium
The products provide researchers and manufacturers with high-performance, scalable and...
Grace Bio-Labs protein microarray tools
Grace Bio-Labs' microarray substrates provide high binding capacity and enable high assay...
Siemens Healthineers 3gAllergy assay
Siemens Healthineers has expanded its 3gAllergy assay menu with nine additional component...
Learn More
I am interested in Odyssey Thera compounding profiling service.
Complete the form and a supplier representative will be in touch.
